Prevoznik Michael E's Form 4 filing
Quest Diagnostics Inc (DGX) · filed May 19, 2022
- Accession no.
- 0001022079-22-000077
- Filed
- May 19, 2022
- Trade date
- May 17, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $7.08M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Prevoznik Michael ECIK 0001222679 | Officer (SVP & General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 17, 2022 | Common Stock | MOption exerciseAcquired | +50,604 | $66.51 | +$3,365,672.04 | 89,828 | Direct | |
| May 17, 2022 | Common Stock | SSaleDisposed | −50,604 | $139.97 | −$7,083,041.88 | 39,224 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 17, 2022 | Common Stock | MOption exerciseDisposed | −50,604 | $66.51 | −$3,365,672.04 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.